Authors

• John Sellinger (ORCID: https://orcid.org/0000-0002-8870-5085)
• Brad Schimelman
• Alicia M Semiatin
• Kathryn Gilstad‐Hayden
• Paul E. Holtzheimer (ORCID: https://orcid.org/0000-0002-3552-3296)
• Christina M. Lazar (ORCID: https://orcid.org/0000-0003-1732-1516)
• Bradley Brummett
• Steve Martino
• Diana M. Higgins
• Tu Ngo
• Nicholas A. Livingston
• Carolyn Solzhenitsyn
• Kristin Mattocks
• Marc I. Rosen
• Paul G. Barnett

Institutions

• Dartmouth College (US)
• Boston University (US)
• Clark University (US)
• University of Massachusetts Chan Medical School (US)
• VA Palo Alto Health Care System (US)
• Providence VA Medical Center (US)
• Yale University (US)
• VA Connecticut Healthcare System (US)
• VA New England Healthcare System (US)
• Manchester VA Medical Center (US)
• National Center for PTSD (US)
• VA Central Western Massachusetts Healthcare System (US)
• James J. Peters VA Medical Center (US)
• White River Junction VA Medical Center (US)
• Durham VA Health Care System (US)

Publication Details

Journal

Journal of General Internal Medicine

Published

2026-02-25

DOI

https://doi.org/10.1007/s11606-025-10127-2

Primary Topic

Opioid Use Disorder Treatment

Type

article

Field-Weighted Citation Impact

0.00

Funders

• National Institute on Alcohol Abuse and Alcoholism
• National Institute on Drug Abuse
• Office of Behavioral and Social Sciences Research
• National Center for Complementary and Integrative Health